Samsung Biologics and Eli Lilly Announce COVID-19 Treatment Production Agreement
Experiencing a major year for growth, Samsung Biologics recently announced yet another strategic agreement with global healthcare leader Eli Lilly. The long-term manufacturing partnership focuses on increasing the supply of …
